(NASDAQ: NDRA) Endra Life Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 40.01%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,337.44%.
Endra Life Sciences's earnings in 2026 is -$7,302,513.On average, 3 Wall Street analysts forecast NDRA's earnings for 2026 to be -$6,023,975, with the lowest NDRA earnings forecast at -$5,787,741, and the highest NDRA earnings forecast at -$6,201,151.
In 2027, NDRA is forecast to generate -$5,181,914 in earnings, with the lowest earnings forecast at -$4,978,702 and the highest earnings forecast at -$5,334,323.